Genital Diseases, Female  >>  amatuximab (MORAb-009)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
amatuximab (MORAb-009) / Eisai
MORAb-009-001, NCT00325494: A Study of MORAb-009 in Subjects With Pancreatic Cancer, Mesothelioma, or Certain Types of Ovarian or Lung Cancer

Completed
1
24
US
MORAb-009
Morphotek
Pancreatic Cancer, Mesothelioma, Ovarian Cancer, Non-Small Cell Lung Cancer
09/08
09/08

Download Options